CIK 0002091349 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
First Tracks Biotherapeutics, Inc.
Sign in to watch- Ticker
- TRAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 395003207
- Phone
- 212-373-3000
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- Biopharma Company, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,145
- in 1 filing
Net −$1,758,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Employee Stock Option (right to buy) | +194,900 | 194,900 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Employee Stock Option (right to buy) | +379,620 | 379,620 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Employee Stock Option (right to buy) | +305,500 | 305,500 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Employee Stock Option (right to buy) | +133,400 | 133,400 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Restricted Stock Unit | +17,850 | 17,850 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Restricted Stock Unit | +69,355 | 69,355 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Restricted Stock Unit | +80,512 | 80,512 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Restricted Stock Unit | +98,600 | 98,600 | ||
| 2026-04-20 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +784 | 784 | ||
| 2026-04-20 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2026-04-20 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +9,200 | 9,200 | ||
| 2026-04-20 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +10,600 | 10,600 | ||
| 2026-04-20 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +16,510 | 16,510 | ||
| 2026-04-20 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +16,510 | 16,510 | ||
| 2026-04-20 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +5,500 | 5,500 | ||
| 2026-04-20 | Marquet Magda Director | Grant or award · Restricted Stock Unit | +6,030 | 6,030 | ||
| 2026-04-20 | Marquet Magda Director | Grant or award · Restricted Stock Unit | +4,000 | 4,000 | ||
| 2026-04-20 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2026-04-20 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2026-04-20 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 |
Page 6 of 8 · 151 trades